These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 17438107)

  • 1. The human T-box mesodermal transcription factor Brachyury is a candidate target for T-cell-mediated cancer immunotherapy.
    Palena C; Polev DE; Tsang KY; Fernando RI; Litzinger M; Krukovskaya LL; Baranova AV; Kozlov AP; Schlom J
    Clin Cancer Res; 2007 Apr; 13(8):2471-8. PubMed ID: 17438107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The T-box transcription factor Brachyury promotes epithelial-mesenchymal transition in human tumor cells.
    Fernando RI; Litzinger M; Trono P; Hamilton DH; Schlom J; Palena C
    J Clin Invest; 2010 Feb; 120(2):533-44. PubMed ID: 20071775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer vaccines targeting the epithelial-mesenchymal transition: tissue distribution of brachyury and other drivers of the mesenchymal-like phenotype of carcinomas.
    Hamilton DH; Litzinger MT; Fernando RI; Huang B; Palena C
    Semin Oncol; 2012 Jun; 39(3):358-66. PubMed ID: 22595058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brachyury, a driver of the epithelial-mesenchymal transition, is overexpressed in human lung tumors: an opportunity for novel interventions against lung cancer.
    Roselli M; Fernando RI; Guadagni F; Spila A; Alessandroni J; Palmirotta R; Costarelli L; Litzinger M; Hamilton D; Huang B; Tucker J; Tsang KY; Schlom J; Palena C
    Clin Cancer Res; 2012 Jul; 18(14):3868-79. PubMed ID: 22611028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant expression of the embryonic transcription factor brachyury in human tumors detected with a novel rabbit monoclonal antibody.
    Hamilton DH; Fernando RI; Schlom J; Palena C
    Oncotarget; 2015 Mar; 6(7):4853-62. PubMed ID: 25605015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological targeting of tumor cells undergoing an epithelial-mesenchymal transition via a recombinant brachyury-yeast vaccine.
    Hamilton DH; Litzinger MT; Jales A; Huang B; Fernando RI; Hodge JW; Ardiani A; Apelian D; Schlom J; Palena C
    Oncotarget; 2013 Oct; 4(10):1777-90. PubMed ID: 24125763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brachyury, a vaccine target, is overexpressed in triple-negative breast cancer.
    Hamilton DH; Roselli M; Ferroni P; Costarelli L; Cavaliere F; Taffuri M; Palena C; Guadagni F
    Endocr Relat Cancer; 2016 Oct; 23(10):783-796. PubMed ID: 27580659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I Study of a Poxviral TRICOM-Based Vaccine Directed Against the Transcription Factor Brachyury.
    Heery CR; Palena C; McMahon S; Donahue RN; Lepone LM; Grenga I; Dirmeier U; Cordes L; Marté J; Dahut W; Singh H; Madan RA; Fernando RI; Hamilton DH; Schlom J; Gulley JL
    Clin Cancer Res; 2017 Nov; 23(22):6833-6845. PubMed ID: 28855356
    [No Abstract]   [Full Text] [Related]  

  • 9. T-box transcription factor brachyury is associated with prostate cancer progression and aggressiveness.
    Pinto F; Pértega-Gomes N; Pereira MS; Vizcaíno JR; Monteiro P; Henrique RM; Baltazar F; Andrade RP; Reis RM
    Clin Cancer Res; 2014 Sep; 20(18):4949-61. PubMed ID: 25009296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and characterization of a cytotoxic T-lymphocyte agonist epitope of brachyury, a transcription factor involved in epithelial to mesenchymal transition and metastasis.
    Tucker JA; Jochems C; Boyerinas B; Fallon J; Greiner JW; Palena C; Rodell TC; Schlom J; Tsang KY
    Cancer Immunol Immunother; 2014 Dec; 63(12):1307-17. PubMed ID: 25186612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Investigation of transcription factor Brachyury (T) expression in human normal and tumor tissues].
    Krukovskaia LL; Polev DE; Nosova IuK; Baranova AV; Koliubaeva SN; Kozlov AP
    Vopr Onkol; 2008; 54(6):739-43. PubMed ID: 19241850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of Brachyury gene is a significant prognostic factor for primary lung carcinoma.
    Haro A; Yano T; Kohno M; Yoshida T; Koga T; Okamoto T; Takenoyama M; Maehara Y
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S509-16. PubMed ID: 23456319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of Cancer Vaccines Targeting Brachyury, a Transcription Factor Associated with Tumor Epithelial-Mesenchymal Transition.
    Hamilton DH; David JM; Dominguez C; Palena C
    Cells Tissues Organs; 2017; 203(2):128-138. PubMed ID: 28214895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. brachyury Target genes in the early sea urchin embryo isolated by differential macroarray screening.
    Rast JP; Cameron RA; Poustka AJ; Davidson EH
    Dev Biol; 2002 Jun; 246(1):191-208. PubMed ID: 12027442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune Targeting of Tumor Epithelial-Mesenchymal Transition via Brachyury-Based Vaccines.
    Palena C; Hamilton DH
    Adv Cancer Res; 2015; 128():69-93. PubMed ID: 26216630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brachyury gene copy number gain and activation of the PI3K/Akt pathway: association with upregulation of oncogenic Brachyury expression in skull base chordoma.
    Otani R; Mukasa A; Shin M; Omata M; Takayanagi S; Tanaka S; Ueki K; Saito N
    J Neurosurg; 2018 May; 128(5):1428-1437. PubMed ID: 28753115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brachyury, the blastopore and the evolution of the mesoderm.
    Technau U
    Bioessays; 2001 Sep; 23(9):788-94. PubMed ID: 11536291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brachyury is expressed by human teratocarcinoma cells in the absence of mesodermal differentiation.
    Gokhale PJ; Giesberts AM; Andrews PW
    Cell Growth Differ; 2000 Mar; 11(3):157-62. PubMed ID: 10768863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-box transcription factor brachyury promotes tumor cell invasion and metastasis in non-small cell lung cancer via upregulation of matrix metalloproteinase 12.
    Wan Z; Jiang D; Chen S; Jiao J; Ji L; Shah AS; Wei H; Yang X; Li X; Wang Y; Xiao J
    Oncol Rep; 2016 Jul; 36(1):306-14. PubMed ID: 27176766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding Molecular Pathways and Targets of Brachyury in Epithelial-mesenchymal Transition (EMT) in Human Cancers.
    Song W; Gobe GC
    Curr Cancer Drug Targets; 2016; 16(7):586-93. PubMed ID: 27018266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.